TUESDAY, Nov. 4, 2025 (HealthDay News) — The head of the U.S. Food and Drug Administration’s (FDA) drug division has resigned while under internal investigation, saying he was pushed out after raising concerns about how the agency planned to fast-track some new drugs. Dr. George Tidmarsh, who joined the FDAContinue Reading